161 related articles for article (PubMed ID: 11078269)
1. Frequency of anticoagulation for atrial fibrillation and reasons for its non-use at a Veterans Affairs medical center.
Bradley BC; Perdue KS; Tisdel KA; Gilligan DM
Am J Cardiol; 2000 Mar; 85(5):568-72. PubMed ID: 11078269
[TBL] [Abstract][Full Text] [Related]
2. Is warfarin really underused in patients with atrial fibrillation?
Weisbord SD; Whittle J; Brooks RC
J Gen Intern Med; 2001 Nov; 16(11):743-9. PubMed ID: 11722687
[TBL] [Abstract][Full Text] [Related]
3. The use of warfarin in veterans with atrial fibrillation.
Bravata DM; Rosenbeck K; Kancir S; Brass LM
BMC Cardiovasc Disord; 2004 Oct; 4(1):18. PubMed ID: 15498102
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
[TBL] [Abstract][Full Text] [Related]
5. Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other Indications.
Bunch TJ; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Jacobs V; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27402230
[TBL] [Abstract][Full Text] [Related]
6. Stroke prevention in atrial fibrillation: are we following the guidelines?
Pusser BE; Robertson SL; Robinson MD; Barton C; Dobson LA
N C Med J; 2005; 66(1):9-13. PubMed ID: 15786672
[TBL] [Abstract][Full Text] [Related]
7. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
[TBL] [Abstract][Full Text] [Related]
8. Use of warfarin for nonvalvular atrial fibrillation in nursing home patients.
Lackner TE; Battis GN
Arch Fam Med; 1995 Dec; 4(12):1017-26. PubMed ID: 7496550
[TBL] [Abstract][Full Text] [Related]
9. Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation.
Lewis WR; Fonarow GC; LaBresh KA; Cannon CP; Pan W; Super DM; Sorof SA; Schwamm LH
Am J Cardiol; 2009 Jan; 103(2):227-31. PubMed ID: 19121441
[TBL] [Abstract][Full Text] [Related]
10. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).
Friberg L; Hammar N; Ringh M; Pettersson H; Rosenqvist M
Eur Heart J; 2006 Aug; 27(16):1954-64. PubMed ID: 16847008
[TBL] [Abstract][Full Text] [Related]
11. Warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the "Real-World" Michigan Anticoagulation Quality Improvement Initiative (MAQI
Hughey AB; Gu X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Besley D; Krol GD; Ahsan S; Kaatz S; Froehlich JB; Barnes GD
J Thromb Thrombolysis; 2018 Oct; 46(3):316-324. PubMed ID: 29948756
[TBL] [Abstract][Full Text] [Related]
12. Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany - results from the German AFNET registry.
Haeusler KG; Gerth A; Limbourg T; Tebbe U; Oeff M; Wegscheider K; Treszl A; Ravens U; Meinertz T; Kirchhof P; Breithardt G; Steinbeck G; Nabauer M;
BMC Neurol; 2015 Aug; 15():129. PubMed ID: 26242880
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation and atrial fibrillation. Putting the results of clinical trials into practice.
Wipf JE
West J Med; 1995 Aug; 163(2):145-52. PubMed ID: 7571562
[TBL] [Abstract][Full Text] [Related]
14. Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.
Ashburner JM; Go AS; Chang Y; Fang MC; Fredman L; Applebaum KM; Singer DE
J Am Geriatr Soc; 2017 Jan; 65(1):35-41. PubMed ID: 27861698
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
16. Eligibility and preference of new oral anticoagulants in patients with atrial fibrillation: comparison between patients with versus without stroke.
Yoon CH; Park YK; Kim SJ; Lee MJ; Ryoo S; Kim GM; Chung CS; Lee KH; Kim JS; Bang OY
Stroke; 2014 Oct; 45(10):2983-8. PubMed ID: 25147329
[TBL] [Abstract][Full Text] [Related]
17. Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals.
Munschauer FE; Priore RL; Hens M; Castilone A
Stroke; 1997 Jan; 28(1):72-6. PubMed ID: 8996492
[TBL] [Abstract][Full Text] [Related]
18. Warfarin use in nursing home residents: results from the 2004 national nursing home survey.
Ghaswalla PK; Harpe SE; Slattum PW
Am J Geriatr Pharmacother; 2012 Feb; 10(1):25-36.e2. PubMed ID: 22226690
[TBL] [Abstract][Full Text] [Related]
19. Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting.
Han SY; Palmeri ST; Broderick SH; Hasselblad V; Rendall D; Stevens S; Tenaglia A; Velazquez E; Whellan D; Wagner G; Heitner JF
J Electrocardiol; 2013; 46(1):45-50. PubMed ID: 23063241
[TBL] [Abstract][Full Text] [Related]
20. Effective anticoagulation therapy: defining the gap between clinical studies and clinical practice.
Wittkowsky AK
Am J Manag Care; 2004 Oct; 10(10 Suppl):S297-306; discussion S312-7. PubMed ID: 15605700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]